Sergio Hickey, MD
General Practice · Pittsburgh, PANPI 1902143811
Payments from drug & device makers
What this record shows
20 manufacturers reported payments, led by Medtronic at 34.0% of the total. Among general practice clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 179 payments — averaging $80.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$5K
- Abbott$2K
- Relievant Medsystems, Inc.$2K
- Stimwave Technologies Incorporated$2K
- Stryker$1K
- Pacira Pharmaceuticals Incorporated$905
- plus $2K from 14 others
What the payments were for
- Travel & lodging$8,31758%
- Food & beverage$6,09542%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 62 | $4,895 |
| Abbott | 28 | $2,452 |
| Relievant Medsystems, Inc. | 7 | $1,522 |
| Stimwave Technologies Incorporated | 12 | $1,514 |
| Stryker | 6 | $1,116 |
| Pacira Pharmaceuticals Incorporated | 6 | $905 |
| Vertos Medical, Inc. | 4 | $404 |
| Nevro Corp. | 6 | $313 |
| AbbVie | 13 | $246 |
| Saluda Medical Americas, Inc. | 18 | $225 |
| Averitas Pharma Inc. | 2 | $211 |
| GRT US Holding, Inc. | 2 | $150 |
| Si-bone, Inc. | 1 | $121 |
| Boston Scientific | 2 | $120 |
| Avanos Medical | 1 | $76 |
| Curonix LLC | 3 | $45 |
| Nalu Medical, Inc. | 2 | $34 |
| Pfizer | 2 | $30 |
| SPR Therapeutics, Inc | 1 | $18 |
| Novo Nordisk | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Intracept$5,547
- StimQ Receiver Stimulator Kit Channel A US w Receiver$1,182
- StimQ Freedom-4A Receiver Kit Channel A US w/ Receiver$1,182
- StimQ Freedom 8A Receiver Kit Channel A US w Receiver$1,182
- Freedom 4A Receiver Kit Channel A US w Receiver$1,182
- Freedom 8A Receiver Kit Channel A US w Receiver$1,182
- SPINEJACK$997
- OSTEOCOOL RF ABLATION SYSTEM$920
- INTELLIS ADAPTIVESTIM$919
- Iovera$725
- Axium$710
- PROCLAIM$687
- KYPHON EXPRESS II KYPHOPAK TRAY$508
- INTELLIS$478
- mild Device Kit$329
- Qutenza$280
- Proclaim IPG$241
- FUSION$159
- INCEPTIV$151
- IonicRF$130
How this compares
$14,413 in reported general payments places this provider in the 95th percentile of 3,208 general practice providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Emgality PenGalcanezumab-Gnlm | 30 | $20,914 |
| Nurtec OdtRimegepant Sulfate | 14 | $14,352 |
| Buprenorphine | 28 | $8,234 |
| Aimovig AutoinjectorErenumab-Aooe | 11 | $7,930 |
| MovantikNaloxegol Oxalate | 12 | $7,704 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 240 | $5,500 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 297 | $5,364 |
| Pregabalin | 118 | $4,757 |
| Gabapentin | 235 | $3,932 |
| OxycontinOxycodone Hcl | 12 | $3,678 |
| Celecoxib | 38 | $2,778 |
| Oxycodone Hcl | 75 | $2,294 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 14 | $1,605 |
| Oxymorphone Hcl ErOxymorphone Hcl | 12 | $1,328 |
| Morphine Sulfate ErMorphine Sulfate | 36 | $915 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerNurtec Odt | $30 | $14,35214 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,208 general practice providers in Pennsylvania.
Other general practice in Pittsburgh
- Susan McMahonPittsburgh$364K
- Gordon OttPittsburgh$60K
- Richard SullivanPittsburgh$9K
- Rebecca PoundsPittsburgh$8K
- Joyce WarwickPittsburgh$6K
- Corey AnolikPhiladelphia$2.1M
- Richard NagelbergPlymouth Meeting$1.4M
- Alan AtlasPhiladelphia$486K
- Carl MedgausMonroeville$192K
- Yooson KimMorgantown$166K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.